Doxorubicin-conjugated siRNA lipid nanoparticles for combination cancer therapy.
Butowska K, Han X, Gong N, El-Mayta R, Haley RM, Xue L, Zhong W, Guo W, Wang K, Mitchell MJ.
Butowska K, et al. Among authors: wang k.
Acta Pharm Sin B. 2023 Apr;13(4):1429-1437. doi: 10.1016/j.apsb.2022.07.011. Epub 2022 Jul 21.
Acta Pharm Sin B. 2023.
PMID: 37139433
Free PMC article.